Genenta Science (GNTA) Competitors $3.05 +0.04 (+1.33%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GNTA vs. FENC, VOR, JBIO, EDIT, ALLO, DBVT, IMMP, PRQR, IMRX, and PBYIShould you be buying Genenta Science stock or one of its competitors? The main competitors of Genenta Science include Adherex Technologies (FENC), Vor Biopharma (VOR), Jade Biosciences (JBIO), Editas Medicine (EDIT), Allogene Therapeutics (ALLO), DBV Technologies (DBVT), Prima BioMed (IMMP), ProQR Therapeutics (PRQR), Immuneering (IMRX), and Puma Biotechnology (PBYI). These companies are all part of the "pharmaceutical products" industry. Genenta Science vs. Its Competitors Adherex Technologies Vor Biopharma Jade Biosciences Editas Medicine Allogene Therapeutics DBV Technologies Prima BioMed ProQR Therapeutics Immuneering Puma Biotechnology Adherex Technologies (NASDAQ:FENC) and Genenta Science (NASDAQ:GNTA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. Is FENC or GNTA more profitable? Genenta Science has a net margin of 0.00% compared to Adherex Technologies' net margin of -35.05%. Company Net Margins Return on Equity Return on Assets Adherex Technologies-35.05% N/A -23.92% Genenta Science N/A N/A N/A Do institutionals and insiders have more ownership in FENC or GNTA? 55.5% of Adherex Technologies shares are held by institutional investors. Comparatively, 15.1% of Genenta Science shares are held by institutional investors. 11.0% of Adherex Technologies shares are held by insiders. Comparatively, 29.0% of Genenta Science shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has preferable valuation and earnings, FENC or GNTA? Adherex Technologies has higher revenue and earnings than Genenta Science. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdherex Technologies$47.54M5.20-$440K-$0.42-21.07Genenta ScienceN/AN/A-$9.64MN/AN/A Does the media refer more to FENC or GNTA? In the previous week, Adherex Technologies had 1 more articles in the media than Genenta Science. MarketBeat recorded 2 mentions for Adherex Technologies and 1 mentions for Genenta Science. Genenta Science's average media sentiment score of 1.89 beat Adherex Technologies' score of 1.62 indicating that Genenta Science is being referred to more favorably in the news media. Company Overall Sentiment Adherex Technologies Very Positive Genenta Science Very Positive Do analysts rate FENC or GNTA? Adherex Technologies currently has a consensus target price of $13.33, indicating a potential upside of 50.66%. Genenta Science has a consensus target price of $25.00, indicating a potential upside of 719.94%. Given Genenta Science's higher possible upside, analysts plainly believe Genenta Science is more favorable than Adherex Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adherex Technologies 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00Genenta Science 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, FENC or GNTA? Adherex Technologies has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500. Comparatively, Genenta Science has a beta of 0.62, meaning that its stock price is 38% less volatile than the S&P 500. SummaryAdherex Technologies and Genenta Science tied by winning 6 of the 12 factors compared between the two stocks. Get Genenta Science News Delivered to You Automatically Sign up to receive the latest news and ratings for GNTA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GNTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GNTA vs. The Competition Export to ExcelMetricGenenta ScienceMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$55.05M$3.12B$5.73B$10.31BDividend YieldN/A2.36%5.90%4.63%P/E RatioN/A21.1675.8626.51Price / SalesN/A446.35528.74123.58Price / CashN/A45.4037.1760.46Price / Book4.129.6212.796.29Net Income-$9.64M-$53.28M$3.28B$270.51M7 Day Performance-11.37%0.31%0.22%2.15%1 Month Performance-13.50%4.58%4.61%6.35%1 Year Performance-17.15%9.24%68.33%25.48% Genenta Science Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GNTAGenenta Science2.7535 of 5 stars$3.05+1.3%$25.00+719.9%-22.6%$55.05MN/A0.007FENCAdherex Technologies2.4814 of 5 stars$9.00-0.3%$13.33+48.2%+58.5%$252.03M$47.54M-21.5010VORVor Biopharma2.5144 of 5 stars$1.99+0.3%$6.07+205.6%+52.4%$251.47MN/A-1.20140News CoverageInsider TradeJBIOJade Biosciences2.3862 of 5 stars$7.61+1.7%$16.00+110.2%N/A$248.31MN/A-0.2520EDITEditas Medicine4.1928 of 5 stars$2.77-0.9%$5.10+84.4%-32.4%$247.73M$32.31M-0.97230ALLOAllogene Therapeutics2.8256 of 5 stars$1.12-2.2%$8.44+657.3%-61.1%$247.40M$20K-1.00310Analyst DowngradeDBVTDBV Technologies2.8696 of 5 stars$8.92+2.5%$14.75+65.4%+172.8%$244.38M$4.15M-1.8780Short Interest ↑IMMPPrima BioMed1.6106 of 5 stars$1.65-4.4%$7.00+325.5%-34.5%$241.47M$6.69M0.002,021PRQRProQR Therapeutics2.6394 of 5 stars$2.27-2.8%$8.00+253.2%+7.6%$238.30M$20.46M-4.92180News CoveragePositive NewsShort Interest ↑IMRXImmuneering3.4461 of 5 stars$6.61+11.0%$13.00+96.8%+289.1%$238.30M$320K-3.4760Analyst ForecastGap UpPBYIPuma Biotechnology3.7969 of 5 stars$4.72+3.4%$7.00+48.5%+83.4%$238.00M$238.06M4.82200News CoveragePositive News Related Companies and Tools Related Companies Adherex Technologies Competitors Vor Biopharma Competitors Jade Biosciences Competitors Editas Medicine Competitors Allogene Therapeutics Competitors DBV Technologies Competitors Prima BioMed Competitors ProQR Therapeutics Competitors Immuneering Competitors Puma Biotechnology Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GNTA) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genenta Science S.p.A. Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Genenta Science With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNTA Stock Alerts